CD4 and cancer: Downregulation of ZNF334 expression has been reported in various cancer tissues and in the CD4 + T cells of patients with rheumatoid arthritis (Cheng et al, 2022; Li et al, 2024; Soroczynska-Cybula et al, 2011).